. Author manuscript; available in PMC: 2020 Sep 23.

Published in final edited form as: Plast Reconstr Surg. 2019 Jan;143(1):22e–31e. doi: 10.1097/PRS.0000000000005096

Table 7 –

Linear Regression SF36-PHC and SF36-MHC

	SF36-PHC long term				SF36-MHC long term
	Coef.	P-Value	[95% Conf. Interval]		Coef.	P-Value	[95% Conf. Interval]
Age	−0.69	0.046	−1.37	−0.01	−0.24	0.50	−0.97	0.48
Obesity	−20.08	<0.0001	−30.09	−10.07	−15.00	0.007	−25.59	−4.41
Follow up period (years)	−2.38	0.13	−5.46	0.69	−0.89	0.59	−4.15	2.37
Diabetes	8.26	0.44	−12.91	29.43	16.08	0.16	−6.53	38.68
Hypertension	2.58	0.63	−8.13	13.28	−3.31	0.56	−14.74	8.11
Coronary Artery Disease	−10.91	0.26	−30.14	8.31	−6.30	0.53	−26.60	14.00
Dyslipidemia	−0.12	0.98	−10.52	10.28	−4.14	0.46	−15.22	6.95
Active Smoking	−3.31	0.61	−16.22	9.60	0.36	0.96	−13.31	14.03
Preoperative chemotherapy	1.24	0.75	−6.64	9.12	1.93	0.65	−6.47	10.32
SF36 component score preoperative	0.80	<0.0001	0.51	1.09	0.48	<0.0001	0.25	0.71
laterality (unilateral/bilateral)	−2.91	0.47	−11.01	5.18	−5.29	0.22	−13.93	3.35
Constant	89.56	0.004	31.01	148.11	79.81	0.011	18.95	140.67
	Prob>F <0.0001, R² = 0.6817				Prob>F = 0.0002, R² = 0.5526